Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

17 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Erythroderma in a patient with chronic myelomonocytic leukemia.
Trepanowski N, Cavanaugh-Hussey MW, Dufner RY, Eichstadt S, Lin WM, Shi CR, Mahalingam M, Hartman RI. Trepanowski N, et al. Among authors: eichstadt s. JAAD Case Rep. 2022 Jun 22;26:61-65. doi: 10.1016/j.jdcr.2022.06.008. eCollection 2022 Aug. JAAD Case Rep. 2022. PMID: 35880025 Free PMC article. No abstract available.
Semantic Description of Quality of Data in Sensor Networks.
Vedurmudi AP, Neumann J, Gruber M, Eichstädt S. Vedurmudi AP, et al. Among authors: eichstadt s. Sensors (Basel). 2021 Sep 28;21(19):6462. doi: 10.3390/s21196462. Sensors (Basel). 2021. PMID: 34640782 Free PMC article.
Phase II Open-Label, Single-Arm Trial to Investigate the Efficacy and Safety of Topical Remetinostat Gel in Patients with Basal Cell Carcinoma.
Kilgour JM, Shah A, Urman NM, Eichstadt S, Do HN, Bailey I, Mirza A, Li S, Oro AE, Aasi SZ, Sarin KY. Kilgour JM, et al. Among authors: eichstadt s. Clin Cancer Res. 2021 Sep 1;27(17):4717-4725. doi: 10.1158/1078-0432.CCR-21-0560. Epub 2021 Aug 6. Clin Cancer Res. 2021. PMID: 34362809 Free PMC article. Clinical Trial.
From Clinical Phenotype to Genotypic Modelling: Incidence and Prevalence of Recessive Dystrophic Epidermolysis Bullosa (RDEB).
Eichstadt S, Tang JY, Solis DC, Siprashvili Z, Marinkovich MP, Whitehead N, Schu M, Fang F, Erickson SW, Ritchey ME, Colao M, Spratt K, Shaygan A, Ahn MJ, Sarin KY. Eichstadt S, et al. Clin Cosmet Investig Dermatol. 2019 Dec 24;12:933-942. doi: 10.2147/CCID.S232547. eCollection 2019. Clin Cosmet Investig Dermatol. 2019. PMID: 31920360 Free PMC article.
Phase 1/2a clinical trial of gene-corrected autologous cell therapy for recessive dystrophic epidermolysis bullosa.
Eichstadt S, Barriga M, Ponakala A, Teng C, Nguyen NT, Siprashvili Z, Nazaroff J, Gorell ES, Chiou AS, Taylor L, Khuu P, Keene DR, Rieger K, Khosla RK, Furukawa LK, Lorenz HP, Marinkovich MP, Tang JY. Eichstadt S, et al. JCI Insight. 2019 Oct 3;4(19):e130554. doi: 10.1172/jci.insight.130554. JCI Insight. 2019. PMID: 31578311 Free PMC article. Clinical Trial.
17 results